Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 10 of 15
Postbiotica
Siryo S.p.A.
ItalySector
Biotech
InvestorSiryo
Entry
2021
Hold
5yr
Pow.Bio
Hitachi Ventures Fund III
United StatesSector
Biotech
InvestorHitachi Ventures
Entry
2023
Hold
3yr
PreComb
HTGF III
SwitzerlandSector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
Prilenia Therapeutics
SV7 Impact Medicine Fund
NetherlandsSector
Biotech
InvestorSV Health Managers
Entry
2022
Hold
4yr
PRIMACYT Cell Culture Technology GmbH
Technologiefonds Mecklenburg-Vorpommern
GermanySector
Biotech
InvestorGENIUS Venture Capital
Entry
2004
Hold
22yr
Prosion
Freigeist Deep-Tech Evergreen
GermanySector
Biotech
InvestorFreigeist Capital
Entry
2022
Hold
4yr
Provectus Algae
Hitachi Ventures Fund II
Australia
Sector
Biotech
InvestorHitachi Ventures
Entry
2021
Hold
5yr
Provirex
Bioventure Club Deals
GermanySector
Biotech
InvestorBioventure Management
Entry
2022
Hold
4yr
Provolut
Atlantic Labs I
GermanySector
Biotech
InvestorAtlantic Labs
Entry
2025
Hold
1yr
PureTech
Vitruvian Investment Partnership IV
United StatesSector
Biotech
InvestorVitruvian Partners
Entry
2020
Hold
6yr
Qkine
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2020
Hold
6yr
QurAlis
Dementia Discovery Fund
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2020
Hold
6yr
Ray Therapeutics
4BIO Ventures III
USSector
Biotech
Investor4Bio Partners
Entry
2021
Hold
5yr
Reacta Healthcare
Development Bank of Wales (Balance Sheet)
UKSector
Biotech
InvestorDevelopment Bank of Wales
Entry
2019
Hold
7yr
Recode Therapeutics
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Relation Therapeutics
Hitachi Ventures Fund III
United KingdomSector
Biotech
InvestorHitachi Ventures
Entry
2024
Hold
2yr
ReNeuron
Rosetta Capital V
UKSector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Repairon
Bioventure Club Deals
GermanySector
Biotech
InvestorBioventure Management
Entry
2025
Hold
1yr
Resalis Therapeutics
Claris Biotech I
ItalySector
Biotech
InvestorClaris Ventures SGR
Entry
2021
Hold
5yr
Resolution Therapeutics
Old College Capital LP
UKSector
Biotech
InvestorOld College Capital
Entry
2020
Hold
6yr
Resolve Biosciences
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2020
Hold
6yr
Revel Pharmaceuticals
KIZOO Evergreen (Balance Sheet)
United StatesSector
Biotech
InvestorKIZOO Technology Capital
Entry
2020
Hold
6yr
Revivo BioSystems
Evonik Venture Capital
Singapore
Sector
Biotech
InvestorEvonik Venture Capital
Entry
2021
Hold
5yr
Rgenta
Boehringer Ingelheim Venture Fund
United StatesSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
7yr
RinRi Therapeutics
Boehringer Ingelheim Venture Fund
United KingdomSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
7yr
Rondo Therapeutics
SV7 Impact Medicine Fund
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2022
Hold
4yr
Samsara Therapeutics
Apollo Health Ventures Fund I
United KingdomSector
Biotech
InvestorApollo Health Ventures
Entry
2019
Hold
7yr
Sano Genetics
MMC Ventures EIS Fund
UKSector
Biotech
InvestorMMC Ventures
Entry
2022
Hold
4yr
Scenic Biotech
Oxford Science Enterprises Balance Sheet
NetherlandsSector
Biotech
InvestorOxford Science Enterprises
Entry
2017
Hold
9yr
Seamless Therapeutics
Wellington Partners Life Sciences
GermanySector
Biotech
InvestorWellington Partners
Entry
2023
Hold
3yr
Semarion
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2022
Hold
4yr
Sensible Bio
Backed Fund III
USASector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Serna Bio
Backed Fund III
USASector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
SignaCor
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2024
Hold
2yr
Silthera
Scientifica S.p.A. (Balance Sheet)
ItalySector
Biotech
InvestorScientifica Venture Capital
Entry
2025
Hold
1yr
SIRS Therapeutics
Wellington Partners Life Sciences
GermanySector
Biotech
InvestorWellington Partners
Entry
2020
Hold
6yr
Sitryx
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2023
Hold
3yr
SMIN Therapeutics GmbH
Technologiefonds Hessen
GermanySector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2023
Hold
3yr
SNIPR Biome
Wellington Partners Life Sciences
DenmarkSector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
SonoThera
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2026
Hold
0yr
Spiral Therapeutics
Inveready Biotech II
United StatesSector
Biotech
InvestorInveready Asset Management
Entry
2019
Hold
7yr
Splice Bio
Sabadell Asabys Health Innovation Investments
SpainSector
Biotech
InvestorAsabys Partners
Entry
2022
Hold
4yr
SpliceBio
Ysios BioFund III
ES
Sector
Biotech
InvestorYsios Capital Partners
Entry
2020
Hold
6yr
SpyBiotech
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2017
Hold
9yr
SRTD biotech
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
Stereo Dive
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2023
Hold
3yr
STORM Therapeutics
CIC Fund I
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2016
Hold
10yr
STRM.BIO
Boehringer Ingelheim Venture Fund
United StatesSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2021
Hold
5yr
Sunrock Biopharma, S.L.
SODIGA Galicia
SpainSector
Biotech
InvestorXesGalicia
Entry
2017
Hold
9yr
SuperGround
CHECK24 Impact
FinlandSector
Biotech
InvestorCHECK24 Ventures
Entry
2025
Hold
1yr